FDA Schedules Hearing on CBD, Issues New Press Release and Warning Letters

By Associate Attorney Lauren Mendelsohn April 8, 2019 Last week, the Commissioner of the United States Food and Drug Administration (FDA), Scott Gottlieb, M.D., issued a press release regarding the FDA’s current standpoint with regards to cannabinoids including CBD. In the press release, the FDA states that interest in products […]